# Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers

> **NCT01511497** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 31 (actual)

## Conditions studied

- Pain
- Migraine Disorders

## Interventions

- **BIOLOGICAL:** PF-04427429
- **OTHER:** Normal saline

## Key facts

- **NCT ID:** NCT01511497
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2013-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511497

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511497, "Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01511497. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*